Tijori
Fresenius Kabi Oncology Ltd
Market Capital
₹ 2,255 Cr.
P/E
140.86
  • Fresenius Kabi Oncology Ltd
  • Overview
  • Connections
  • Financials
  • Shareholding
  • Knowledge Base

  • Price
  • Benchmarking
  • Balance Sheet
  • Profit & Loss
  • Cash Flows
  • Ratios
  • Quarterly Results

  • Overview
  • Trend
  • Detailed

  • Recent News
  • Annual Reports

Fresenius Kabi Oncology Ltd
Data for companies with Market Capital less than 500 Cr is currently being indexed. This will be updated shortly!
Fresenius Kabi Oncology Ltd
Data for companies with Market Cap less than 500 Cr is currently being indexed. This will be updated shortly!
Operational Metrics for Fresenius Kabi Oncol
Pharmaceuticals
-8.20% (as of Aug 20)
Domestic Sales Growth - YoY
Compare with Competitors


Competitors
Peer Name Market Cap.
Fresenius Kabi Oncology Ltd. 2,255
Claris Lifesciences Limited 2,164
Hikal Limited 2,146
Dishman Carbogen Amics Limited 2,394
Indoco Remedies Limited 2,406
Alembic Limited 2,726
Unichem Laboratories Limited 1,743
Novartis India Ltd 1,565
Hester Biosciences Ltd 1,485
Wockhardt Limited 3,047
Healthcare Global Enterprises Limited 1,404
Neuland Laboratories Limited 1,387
Panacea Biotec Limited 1,183
DIL Limited 1,063
Morepen Laboratories Limited 1,044
Anuh Pharma Limited 945
Sequent Scientific Limited 3,630
Wendt (India) Limited 654
TTK Healthcare Limited 646
RPG Life Sciences Limited 644
Gufic Biosciences Limited 630
Bajaj Healthcare Limited 606
Lincoln Pharmaceuticals Limited 508
Nectar Lifesciences Limited 492
Medicamen Biotech Limited 490
Thyrocare Technologies Limited 4,026
NGL Fine-Chem Limited 463
Zota Healthcare Limited 358
Caplin Point Laboratories Limited 4,173
Themis Medicare Limited 294
Ind-Swift Laboratories Limited 266
Vimta Labs Limited 250
Albert David Limited 237
Bharat Parenterals Limited 235
Everest Organics Limited 211
Vivimed Labs Limited 158
Zim Laboratories Limited 146
Ambalal Sarabhai Enterprises Limited 136
Coral Lab 135
IOL Chemicals and Pharmaceuticals Limited 4,385
Sun Pharma Advanced Research Company Limited 4,402
Dr Agarwals Eye Hospital Ltd. 107
Fredun Pharmaceuticals Limited 92
Himalaya Food lnternational Ltd. 46
Ind-Swift Limited 22
Shilpa Medicare Limited 4,608
FDC Limited 5,711
Strides Pharma Science Limited 5,917
Narayana Hrudayalaya Ltd 6,496
Aarti Drugs Limited 6,879
Eris Lifesciences 7,344
JB Chemicals & Pharmaceuticals Limited 7,391
Merck Limited 8,113
Granules India Limited 9,300
Fortis Healthcare Limited 10,362
Jubilant Life Sciences Limited 11,450
Ajanta Pharma Limited 13,535
Glenmark Pharmaceuticals Limited 13,623
Natco Pharma Limited 16,134
Alembic Pharmaceuticals Limited 18,774
Sanofi India Limited 19,710
Pfizer Limited 22,500
GlaxoSmithKline Pharmaceuticals Limited 26,158
IPCA Laboratories Limited 26,247
Piramal Enterprises Limited 28,092
Alkem Laboratories Limited 33,477
Abbott India Limited 34,438
Cadila Healthcare Limited 39,476
Lupin Limited 45,224
Aurobindo Pharma Limited 45,229
Torrent Pharmaceuticals Limited 46,008
Biocon Limited 51,348
Cipla Limited 62,104
Divi's Laboratories Limited 81,272
Dr. Reddy's Laboratories Limited 85,031
Sun Pharmaceuticals Industries Limited 117,435
Show More
Benchmarking
2396
Balance Sheet
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Profit & Loss
  • Standalone
  • Consolidated
  • View Detailed
(in Rs. Cr.) Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Cash Flow
  • Standalone
  • Consolidated
(in Rs. Cr.) Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
View previous years
View fewer years
Ratios
= Dominant Factor
(in Rs. Cr.) Mar 2009 Mar 2010 Mar 2011
View previous years
View fewer years
Quarterly Results
  • Standalone
  • Consolidated
(in Rs. Cr.) Sep 2011 Dec 2011 Mar 2012 Jun 2012 Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Dec 2013
View previous years
View fewer years
Overview
Shareholder Break-up
Trend
  • 1y
  • 2y
  • 4y
  • 5y
  • 10y